Quinones as anticancer agents: potential bioreductive alkylating agents.
D000230:Adenocarcinoma / Q000188:drug therapy; D000477:Alkylating Agents / Q000627:therapeutic use*; D000818:Animals; D002417:Cattle; D004273:DNA, Neoplasm / Q000378:metabolism; D066298:In Vitro Techniques; D008931:Mitochondria, Muscle / Q000201:enzymology; D008937:Mitomycins / Q000494:pharmacology; D009206:Myocardium / Q000648:ultrastructure; D009247:NADH, NADPH Oxidoreductases / Q000037:antagonists & inhibitors; D009363:Neoplasm Proteins / Q000378:metabolism; D010084:Oxidation-Reduction; D011809:Quinones / Q000378:metabolism / Q000627:therapeutic use*; D012334:RNA, Neoplasm / Q000378:metabolism; D012510:Sarcoma 180 / Q000188:drug therapy; D014451:Ubiquinone / Q000378:metabolism
D000477:Alkylating Agents; D004273:DNA, Neoplasm; D008937:Mitomycins; D009363:Neoplasm Proteins; D011809:Quinones; D012334:RNA, Neoplasm; D014451:Ubiquinone; D009247:NADH, NADPH Oxidoreductases